Acetaminophen and AKI After Aortic Surgery
Study Details
Study Description
Brief Summary
Acute kidney injury is commonly accompanied major complication after aortic surgery.
Cardipulmonary bypass lyses erythrocyte and induces lipid peroxidation. This increases plasma free hemoglobin, F2-isoprostane, and isofuran concentration. Cell free hemoglobin have been reported to be associated with poor prognosis such as acute kidney injury, myocardial infarction, and death.
Acetaminophen is reported to attenuate hemeprotein mediated lipid peroxidation. Thus, investigators hypothesized that acetaminophen might have protective effect on the incidence of acute kidney injury in patients undergoing aortic surgery with moderate hypothermic circulatory arrest.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Acetaminophen group patients receiving acetaminophen |
Drug: Acetaminophen
Acetaminophen 1g IV every 6 hours for a weight > 50kg (maximum of 4g per 24 hours) or 15mg/kg every 6 hours for a weight < 50kg (maximum of 75mg/kg per 24 hours)
|
Placebo Comparator: Placebo group patients receiving equal amount of normal saline |
Other: Placebo
Normal saline 100 ml (equal amount of acetaminophen) IV every 6 hours
|
Outcome Measures
Primary Outcome Measures
- Incidence of acute kidney injury after aortic surgery with moderate hypothermic circulatory arrest [Postoperative 7 days]
Compare the incidence of acute kidney injury within 7 days after surgery. Acute kidney injury is defined using KDIGO criteria.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients undergoing aortic surgery with moderate hypothermic circulatory arrest.
Exclusion Criteria:
-
patients with chronic kidney disease or with dialysis, eGFR < 15ml/min/1.73m2
-
allergy to acetaminophen or propacetamol HCl
-
history of liver cirrhosis or total bilirubin > 2.0mg/dL
- patients taking acetaminophen or diclofenac 4) patients who cannot understand informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Gangnam Severance Hospital | Seoul | Korea, Republic of |
Sponsors and Collaborators
- Gangnam Severance Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- 3-2021-0087